Medarex has successfully completed multiple clinical trials and has partnerships with leading pharmaceutical companies.
Revenue Amount
$10,000,000
ARR
$5,000,000
Founders
David M. Johnson, Sarah L. Smith
Company Description
Medarex is a biotechnology company focused on developing innovative therapeutic products for the treatment of cancer and other diseases. The company utilizes its proprietary technology platform to create monoclonal antibodies and other biologics.